CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,144,286
- in 6 filings, $22.1M under 10b5-1 plans
Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-21 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −12,000 | $26.91 | $323K | 158,800 |
| 2020-09-14 | MATSUI CONNIE Director | Gift | −8,000 | 208,753 | ||
| 2020-09-11 | MATSUI CONNIE Director | Sale | −32,000 | $27.06 | $866K | 216,753 |
| 2020-09-04 | Matsuda Masaru SVP, General Counsel | Exercise or conversion | +6,884 | 13,822 | ||
| 2020-09-04 | Matsuda Masaru SVP, General Counsel | Shares withheld for taxes | −2,380 | $27.70 | $66K | 11,442 |
| 2020-09-04 | Matsuda Masaru SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −6,884 | 13,766 | ||
| 2020-08-20 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −12,000 | $28.30 | $340K | 170,800 |
| 2020-08-14 | Torley Helen President and CEO | Gift | −10,000 | 480,522 | ||
| 2020-08-13 | Daly James M Director | Sale | −34,337 | $29.12 | $1000K | 31,365 |
| 2020-07-20 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −12,000 | $29.01 | $348K | 182,800 |
| 2020-05-22 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +18,613 | $7.14 | $133K | 194,800 |
| 2020-05-22 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Option to Purchase Common Stock | −18,613 | 0 | ||
| 2020-05-20 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +21,387 | $7.14 | $153K | 197,574 |
| 2020-05-20 | LaBarre Michael J. SVP, Chief Technical Officer | Sale | −21,387 | $23.80 | $509K | 176,187 |
| 2020-05-20 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Option to Purchase Common Stock | −21,387 | 18,613 | ||
| 2020-04-30 | Posard Matthew L. Director | Grant or award | +8,829 | 123,753 | ||
| 2020-04-30 | MATSUI CONNIE Director | Grant or award | +8,829 | 248,753 | ||
| 2020-04-30 | Kelley Kenneth J Director | Grant or award | +8,829 | 286,382 | ||
| 2020-04-30 | Henderson Jeffrey William Director | Grant or award | +8,829 | 72,107 | ||
| 2020-04-30 | Daly James M Director | Grant or award | +8,829 | 65,702 |
Page 55 of 59 · 1,177 trades